Glaukos (NYSE:GKOS – Free Report) had its target price boosted by Citigroup from $120.00 to $130.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the medical instruments supplier’s stock. Several other analysts have also issued reports on GKOS. JPMorgan Chase & Co. boosted their price […]

Related Keywords

Alexr Thurman , Marc Stapley , Glaukos Corporation , Cetera Advisors , Citigroup , Bellevue Group , Securities Exchange Commission , Jefferies Financial Group , Needham Company , Magnetar Financial , Jpmorgan Chase Co , Free Report , Financial Group , Truist Financial , Moderate Buy , Get Free Report , Exchange Commission , Director Marc Stapley , Triangle Partners , Glaukos Daily ,